Pharmacy Update

Disclaimer: We are getting frequent COVID-related questions about drug concerns and potential interactions. This information is as May 14, 2020. We will do our best to keep you up to date with this ever evolving situation. This is the most update information at the time of publication.

Note: There are no Food and Drug Administration (FDA) approved therapies for treatment or prevention of COVID-19. If at all possible, it is best to have patients enrolled in a clinical trial. 

ANTICOAGULATION and COVID-19

All hospitalized COVID-19 patients, including non-ICU patients, should receive pharmacological prophylaxis anticoagulation unless contraindicated. ^1-3 There is limited data on outpatient COVID-19 and anticoagulation. Patients should continue to be as active as possible to reduce their thrombotic risk.   Read more →